These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6737386)

  • 1. The use of longterm nifedipine in a patient with Raynaud's syndrome secondary to mixed connective tissue disease.
    Sarkozi J; McCarthy DD; Lee P
    J Rheumatol; 1984 Jun; 11(3):408-10. PubMed ID: 6737386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
    Shcherbakov AB
    Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud's syndrome: diagnosis and therapy].
    Mahler F
    Ther Umsch; 1985 Oct; 42(10):671-7. PubMed ID: 3909486
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual cause of abdominal fullness in a patient with Raynaud's phenomenon. Mixed connective tissue disease.
    Hokama A; Kishimoto K; Nakamoto M; Kinjo N; Kinjo F; Fujita J
    Gut; 2008 Jun; 57(6):733, 820. PubMed ID: 18477675
    [No Abstract]   [Full Text] [Related]  

  • 6. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH; Pachman L; Medof ME
    J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy.
    Haroon M; O'Gradaigh D; Foley-Nolan D
    Rheumatology (Oxford); 2007 Apr; 46(4):718-9. PubMed ID: 17289791
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
    Dunkley L; Green M; Gough A
    Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
    [No Abstract]   [Full Text] [Related]  

  • 9. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nifedipine in Raynaud's disease: a case report.
    Maguire FW
    Del Med J; 1984 Jul; 56(7):393-8. PubMed ID: 6479385
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketanserin versus nifedipine in secondary Raynaud's phenomenon.
    Kirch W; Linder HR; Hutt HJ; Ohnhaus EE; Mahler F
    Vasa; 1987; 16(1):77-80. PubMed ID: 3554811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Whole-blood and plasma viscosity in two cases of mixed connective tissue disease with Raynaud's phenomenon and cold agglutinemia].
    Nakazato K; Sakurai T; Kubota K; Kurabayashi H; Tamura J; Shirakura T
    Rinsho Byori; 1988 Oct; 36(10):1201-4. PubMed ID: 3246733
    [No Abstract]   [Full Text] [Related]  

  • 14. Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
    Matucci Cerinic M; Falcini F; Bartolozzi G; Volpi M
    Int J Clin Pharmacol Res; 1985; 5(1):67-9. PubMed ID: 3997315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine and distal gangrene in Raynaud's phenomenon.
    Rivera Redondo J; Noguerado Asensio A; Alvaro-Gracia Alvaro JM; Laffón Roca A
    J Rheumatol; 1986 Apr; 13(2):464-5. PubMed ID: 3723511
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M; Polaszewska-Muszyńska M; Ukleja-Adamowicz M; Rewakowicz M; Guzowska M; Marunowska A; Jundziłł W; Wodyńska T; Ruchalski M; Strzelecki A
    Kardiol Pol; 1987; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O; Schmidt JF; Ironmann L
    Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract]   [Full Text] [Related]  

  • 18. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L; Hart LL
    Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
    [No Abstract]   [Full Text] [Related]  

  • 19. Raynaud's phenomenon and nifedipine.
    Kraus A
    J Rheumatol; 1989 Jul; 16(7):1013. PubMed ID: 2597264
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the efficacy of the treatment of Raynaud's phenomenon with nifedipine by laser-Doppler flowmetry.
    Belcaro GV; Gabini M; Cacchio M
    Panminerva Med; 1987; 29(3):223-7. PubMed ID: 2962057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.